Name: Amorchem L.P. - BioCentury Company Profiles - BCIQ
Creator: Biocentury

Emerging Company Profile

signInButton

SIGN IN

Find partnering and investment opportunities, uncover and track competitive threats, dive into a company's financing and deal history, its pipeline and molecular targets of interest, and much more. Please note, you are viewing a free version of BCIQ, BioCentury's advanced business intelligence database for the biopharma industry. Request a trial to unlock the full value of BCIQ.

REQUEST A FREE TRIAL

AcquiredOrMerged

Company profiles have been archived if there have been no financings, deals or product updates in BCIQ in the last five years, or the company is out of business.

If you believe a company has been archived in error, please contact us at 

Company profiles have been archived if there have been no financings, deals or product updates in BCIQ in the last five years, or the company is out of business.\nIf you believe a company has been archived in error, please contact us at \nsupport@biocentury.com\n.

Cat-H(AcquiredorMerged)

Historical deals and financings can be found by searching the organization's name in the BCIQ <DEALS> and <FINANCING> Modules.

Default (Company Type Blank)

CategoryHDefault (Company Type Blank)

NonBioPharma

Biopharma related deals can be found by searching the organization's name in the <DEALS> Module.

Cat-H(NonBioPharma)

Biopharma related deals can be found by searching the organization's name in the <DEALS> Module.\n

Amorchem L.P.

AmorChem raises C$44.2M toward second fund

Corbin partners with Proteorex and U of Dundee to identify USP15 inhibitors

Looking beyond VEGF

Universite Laval, AmorChem deal

University of Montreal, AmorChem deal

Roche, AmorChem deal

Roche, AmorChem partner for myotonic muscular dystrophy

AmorChem, Hopital Maisonneuve-Rosemont deal

AmorChem, McGill University deal

AmorChem, McGill University deal